Please Wait.....
Report
Oncology Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
Market Report I 2025-02-27 I 135 Pages I Global Market Insights
The Global Oncology Market was valued at USD 320.3 billion in 2024 and is projected to grow at a CAGR of 10.8% from 2025 to 2034. The rising incidence of cancer worldwide remains the key driver of market expansion, prompting increased demand for advanced treatments and diagnostics. As cancer cases surge across all age groups, healthcare systems are intensifying efforts to improve patient outcomes through novel therapies, precision medicine, and technological advancements in diagnostics. The oncology sector continues to witness significant investment from pharmaceutical and biotechnology firms, leading to groundbreaking innovations in immunotherapies, targeted therapies, and early detection methods. The growing focus on personalized medicine, driven by genomics and biomarker research, is transforming the landscape of cancer treatment. Government initiatives, rising healthcare expenditures, and increased awareness campaigns further contribute to market growth, emphasizing the urgent need for better accessibility to cutting-edge cancer therapies and diagnostics.
The oncology market is categorized into two primary segments: cancer diagnostics and cancer treatment. The cancer treatment segment, valued at USD 174.8 billion in 2024, is anticipated to grow at a CAGR of 11.3% between 2025 and 2034. The expansion of this segment is attributed to an increasing number of cancer diagnoses and regulatory approvals for novel treatments. Recent breakthroughs, including CAR-T cell therapies and next-generation immunotherapies, are reshaping cancer care, offering patients enhanced survival rates and improved quality of life. As pharmaceutical companies accelerate research and development efforts, the pipeline for innovative oncology drugs continues to expand, providing new hope for patients battling various forms of cancer.
Oncology encompasses several cancer types, including lung, prostate, breast, and colorectal cancers. In 2024, the breast cancer segment accounted for USD 63.2 billion, securing a 20% market share. The rising prevalence of breast cancer, coupled with advancements in diagnostic imaging, liquid biopsies, and targeted therapies, fuels the segment's rapid growth. Increased awareness campaigns and enhanced screening programs are enabling early detection, significantly improving treatment success rates. The growing adoption of artificial intelligence in diagnostics and precision medicine in breast cancer treatment is also driving market expansion, paving the way for more effective, patient-centric therapeutic solutions.
U.S. Oncology Market is poised to reach USD 377.1 billion by 2034, positioning the country as a global leader in cancer research and treatment. The increasing cancer burden, combined with strong government support and robust investment from pharmaceutical and biotechnology companies, is accelerating innovation in the oncology sector. With a growing number of hospitals, research institutions, and healthcare providers focusing on developing next-generation diagnostic tools and therapies, the U.S. continues to spearhead advancements in cancer care. The rising adoption of precision oncology, expansion of clinical trials, and continuous improvements in treatment accessibility further strengthen the market's trajectory, ensuring a steady demand for breakthrough cancer treatments and cutting-edge diagnostic technologies.
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of cancer globally
3.2.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
3.2.1.3 Growing number of diagnostic laboratories in developing countries
3.2.1.4 Technological advancements in developed countries
3.2.2 Industry pitfalls and challenges
3.2.2.1 High capital investment coupled with high cost associated with diagnostic imaging system
3.2.2.2 High risk of side effects associated with cancer treatment and risks associated with CT scanners
3.2.2.3 Dearth of well-skilled and trained oncologists and radiologists
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Cancer Diagnostics and Treatment, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Cancer diagnostics
5.2.1 Tumor biomarkers test
5.2.2 Imaging
5.2.3 Biopsy
5.2.4 Liquid biopsy
5.2.5 Immunohistochemistry
5.2.6 In situ hybridization
5.3 Cancer treatment
5.3.1 Chemotherapy
5.3.2 Targeted therapy
5.3.3 Immunotherapy
5.3.4 Hormonal therapy
5.3.5 Other cancer treatments
Chapter 6 Market Estimates and Forecast, By Cancer Type, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Lung cancer
6.3 Prostate cancer
6.4 Colon and rectal cancer
6.5 Gastric cancer
6.6 Esophageal cancer
6.7 Liver cancer
6.8 Breast cancer
6.9 Other cancer types
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Diagnostic imaging centers
7.5 Academia
7.6 Specialty clinics
7.7 Other end use
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.4.6 Thailand
8.4.7 Indonesia
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
Chapter 9 Company Profiles
9.1 AbbVie
9.2 Amgen
9.3 AstraZeneca
9.4 Bristol-Myers Squibb Company
9.5 Eli Lilly and Company
9.6 GE HealthCare Technologies
9.7 Gilead Sciences
9.8 GlaxoSmithKline
9.9 Johnson & Johnson
9.10 Merck & Co
9.11 Novartis
9.12 Pfizer
9.13 F. Hoffmann-La Roche
9.14 Sanofi
9.15 Takeda Pharmaceutical Company Limited
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security